top of page
Insights That Move the GPCR Field Forward
Read the latest analyses, interviews, and discoveries shaping the GPCR ecosystem — from research breakthroughs to biotech strategy.
GPCR News powered by our Strategic Partners
Blog: Blog2
Search
Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
January 2022 Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and Provides Strategy Update...
GPCR News
Jan 1, 20221 min read
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
January 2022 "OXFORD, England--Professor Charlotte Deane, Ph.D., of the University of Oxford, has joined Exscientia as Chief Scientist of...
GPCR News
Jan 1, 20221 min read
Drug Discovery Picks Up the Pace, Stays on Target
January 2022 "Voltaire argued, “Perfection is attained by slow degrees; it requires the hand of time.” However, in drug discovery...
GPCR News
Jan 1, 20221 min read
Learn more about Neurocrine Biosciences with their new video
January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special. It...
GPCR News
Dec 31, 20211 min read
Dr. Nicola J. Smith - Dr. GPCR Podcast
Next on the Dr. GPCR Podcast, we have Dr. Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney. Subscribe...
Dr. GPCR News
Dec 27, 20211 min read
Targeted Therapies to Reduce Side Effects in Modern Drug Development
December 2021 "Drug development is rarely trivial. In fact, it is often costly, frustrating, and tortuous—and more often than not it...
GPCR News
Dec 1, 20211 min read
Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
December 2021 "Dame Carol Robinson DBE, FRS, FRSC, FMedSci, Oxford University’s first female Professor of Chemistry, former president of...
GPCR News
Dec 1, 20211 min read
Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research
December 2021 "Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research. Peter joined Tectonic to help chart new territory in GPCR...
GPCR News
Dec 1, 20211 min read
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
December 2021 "Tokyo, Japan and Cambridge, UK, 24 December 2021 – Sosei Group Corporation (“Sosei Heptares”; TSE: 4565) today announces...
GPCR News
Dec 1, 20211 min read
Addex Raises $10 Million In Equity Financing
December 2021 "Geneva, Switzerland, December 17, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...
GPCR News
Nov 30, 20211 min read
Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
December 2021 "3-part randomized, double-blind, placebo-controlled Phase 1 study will evaluate TRV045 safety, tolerability, and PK in...
GPCR News
Nov 30, 20211 min read
Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the...
GPCR News
Nov 30, 20211 min read
VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
December 2021 "30/11/2021 Confo will work together with Regeneron to apply its GPCR drug discovery platform to enable functional antibody...
GPCR News
Nov 30, 20211 min read
Crinetics Pharmaceuticals announced the formation of an independently operated new company...
December 2021 Crinetics Pharmaceuticals announced the formation of an independently operated new company, Radionetics Oncology....
GPCR News
Nov 30, 20211 min read
Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company unlocking the therapeutic...
GPCR News
Nov 30, 20211 min read
Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
December 2021 Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated...
GPCR News
Nov 30, 20211 min read
First in Human: Early-stage COVID therapies hold promise against omicron variant
December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and Trevena Inc. could offer potential...
GPCR News
Nov 30, 20211 min read
OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
December 2021 OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet Prize for Medicine 2022 by the...
GPCR News
Nov 30, 20211 min read
Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
December 2022 Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic...
GPCR News
Nov 30, 20211 min read
New structural perspectives in G protein-coupled receptor-mediated Src family kinase activation
Excited to hear Dr. Sandra Berndt talk about new structural perspectives in GPCR-mediated Src family kinase activation. Register here...
Dr. GPCR News
Nov 25, 20211 min read
Dr. Peter Robert Banks - Dr. GPCR Podcast
Ep 57 of the Dr. GPCR podcast is now available! Our guest is Dr. Peter Banks, Scientific Director at BioTek Instruments! Learn about his...
Dr. GPCR News
Nov 25, 20211 min read
Dr. Adriano Marchese - Dr. GPCR Podcast
Episode 56 of the Dr. GPCR podcast is now available! Our guest is Dr. Adriano Marchese! Learn about his remarkable career and research in...
Dr. GPCR News
Nov 18, 20211 min read
Automated micro-plate-based methods for quantifying GPCR activation
Excited to hear Dr. Joe Clayton from BioTek Instruments talk about automated micro-plate-based methods for quantifying #GPCR activation....
Dr. GPCR News
Nov 18, 20211 min read
Dr. JoAnn Trejo - Dr. GPCR Podcast
Episode 54 of the Dr. GPCR podcast is now available! Our guest is Dr. JoAnn Trejo! Sharing how she became a scientist, educator, mentor,...
Dr. GPCR News
Nov 3, 20211 min read
bottom of page